According to Assertio Therapeutics 's latest financial reports the company's total liabilities are $0.14 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $0.14 B | -21.13% |
2022-12-31 | $0.18 B | -16.04% |
2021-12-31 | $0.22 B | -9.54% |
2020-12-31 | $0.24 B | -47.2% |
2019-12-31 | $0.46 B | -34.15% |
2018-12-31 | $0.71 B | -18.02% |
2017-12-31 | $0.86 B | -10.82% |
2016-12-31 | $0.97 B | -6.49% |
2015-12-31 | $1.04 B | 200.68% |
2014-12-31 | $0.34 B | -6.63% |
2013-12-31 | $0.37 B | 543.2% |
2012-12-31 | $57.71 M | -1.26% |
2011-12-31 | $58.45 M | -8.56% |
2010-12-31 | $63.92 M | -15.73% |
2009-12-31 | $75.85 M | 22.48% |
2008-12-31 | $61.93 M | 76.32% |
2007-12-31 | $35.12 M | -56.04% |
2006-12-31 | $79.9 M | 33.95% |
2005-12-31 | $59.65 M | 312.39% |
2004-12-31 | $14.46 M | 10.28% |
2003-12-31 | $13.11 M | -55.68% |
2002-12-31 | $29.59 M | 189.45% |
2001-12-31 | $10.22 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.62 B | 319.42% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $12.01 M | -91.91% | ๐บ๐ธ USA |